Not applicableNo Longer AvailableNCT01947608What this trial is testingExpanded Treatment Protocol With LDK378 in ALK(+) NSCLCWho this might be right forNon-small Cell Lung Cancer (NSCLC) Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT01346540What this trial is testingA Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.Who this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Study completedNCT00049140What this trial is testingEF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer David M. Brizel, MD 8
Testing effectiveness (Phase 2)UnknownNCT03121313What this trial is testingMaintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+Who this might be right forSquamous Cell Carcinoma of Oral Cavity Chang Gung Memorial Hospital 68
Early research (Phase 1)Looking for participantsNCT07755397What this trial is testingFirst in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands TumorWho this might be right forNSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck Jubilant Therapeutics India Limited 30
Large-scale testing (Phase 3)WithdrawnNCT01142414What this trial is testingChemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of RecurrenceWho this might be right forHead and Neck Cancer European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT00530621What this trial is testingStudy of Enzastaurin Versus Placebo With Pemetrexed for Participants With Advanced or Metastatic Lung CancerWho this might be right forNon-small Cell Lung Cancer Eli Lilly and Company 160
Large-scale testing (Phase 3)Study completedNCT00069121What this trial is testingXeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon CancerWho this might be right forColorectal Cancer Hoffmann-La Roche 1,886
Early research (Phase 1)Ended earlyNCT01975688What this trial is testingA Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced MucositisWho this might be right forHead and Neck Squamous Cell Carcinoma GW Pharmaceuticals Ltd 10
Early research (Phase 1)Looking for participantsNCT06046495What this trial is testingThe Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Avistone Biotechnology Co., Ltd. 81
Post-approval studies (Phase 4)Study completedNCT00844675What this trial is testingEffects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal ResectionWho this might be right forEarly Gastric AdenocarcinomaAdenocarcinoma, Tubular The Catholic University of Korea 120
Not applicableStudy completedNCT00899821What this trial is testingMicrosphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer NYU Langone Health
Not applicableStudy completedNCT03788499What this trial is testingUsing Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral MucositisWho this might be right forNasopharyngeal Carcinoma Xinqiao Hospital of Chongqing 160
Large-scale testing (Phase 3)WithdrawnNCT00041171What this trial is testingDocetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryWho this might be right forAdult Solid TumorBreast CancerHead and Neck Cancer+3 more Alliance for Clinical Trials in Oncology
Early research (Phase 1)Study completedNCT01198821What this trial is testingGem-TABS in Unresectable Pancreatic CarcinomaWho this might be right forPancreatic Cancer H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT01466244What this trial is testingBiomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397Who this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group 42
Early research (Phase 1)Study completedNCT00215956What this trial is testingA Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal CarcinomaWho this might be right forRectal Neoplasms H. Lee Moffitt Cancer Center and Research Institute 31
Not applicableActive Not RecruitingNCT07556367What this trial is testingPost-Radiation Oral Health in Underserved Head and Neck Cancer PatientsWho this might be right forHead and Neck CancerHead and Neck CarcinomaHead and Neck Neoplasms University of California, San Francisco 43
Early research (Phase 1)Study completedNCT00514007What this trial is testingStudy of Continuous OSI-906 DosingWho this might be right forAdvanced Solid Tumors Astellas Pharma Inc 95
Testing effectiveness (Phase 2)Study completedNCT00076609What this trial is testingStudy of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver Cancer PhytoCeutica 31